Janux Therapeutics

Last updated: September 01, 2025

Founder David Campbell
Founder David Campbell
USA | Funding: $898.9M (+)

Website: https://www.januxrx.com

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.